NCT05225870View on ClinicalTrials.gov

Significance of Cortactin Expression in Colorectal Adenocarcinomas

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

December 30, 2021

Conditions
Cancer Colon
Interventions
GENETIC

immunohistochemical staining

sections from colorectal carcinoma will be immunohistochemically stained by anti-Cortactin antobody.

Trial Locations (1)

82524

Maisa Hashem Mohammed, Sohag

All Listed Sponsors
lead

Sohag University

OTHER

NCT05225870 - Significance of Cortactin Expression in Colorectal Adenocarcinomas | Biotech Hunter | Biotech Hunter